Delivery Order SPE2DB22D2206-SPE2DB24FFN60
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of LAGEVRIO 200 MG CAP (EUA) UU 40S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The award, valued at $7,147.20, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a ceiling value of up to $999,999,999.00 and runs through December 31, 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,743.99 for the supply of 60 capsules of the medication Lubiprostone 24 MCG. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 7, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, a major pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,946.28 for pharmaceutical and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of June 18, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,157.25 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) for pharmaceutical and medical supply services. The contract supports the DLA in providing essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to military treatment facilities,...
- This federal contract award is a delivery order valued at $1,253.28 awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is for the provision of pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB20D2104|SPE2DB24FT00S) valued at $1,182.71 for pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 2, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $7,166.46 issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical products. The contract has a performance period through January 29, 2021 and is a firm-fixed price arrangement. Amerisourcebergen is an experienced pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $6,406.86 with an ultimate completion date of November 17, 2023. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
- This federal contract award, valued at $678,553.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,714.22 for pharmaceutical and medical supply distribution. The contract was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 3, 2020. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FFN60Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $6,379.88 for the drug LAGEVRIO 200 MG CAP (EUA). The award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, and has a completion date of February 9, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This delivery order is part of the company's broader contracting relationship with the DLA to efficiently deliver essential medical commodities to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.4k | 2/8/24 |